A Guide to Choosing the Right CRO for Transient Recombinant Antibody Production

Transient recombinant antibody production is a critical step, whether you are conducting fundamental research, developing diagnostics, or advancing a candidate toward therapeutic use. In this fast-paced world of research and antibody development, where speed, flexibility, and reliability are essential, choosing the right partner is key to accelerating timelines, optimizing budgets, and ensuring higher-quality results.

In this article, we break down the key criteria to consider when selecting a provider for transient antibody expression and how Proteogenix delivers on each one.

1. Speed and Turnaround Time

In antibody discovery and development, time is often the most valuable resource. Transient production is commonly used during early discovery or candidate screening phases, where time is critical since minor delays at this point can hold back the entire development program. 

Key factors to consider: 

• Typical turnaround times (e.g. 1–3 weeks for small-scale production)
• Proven track record for delivering on time
• Rapid response to quote requests, inquiries and technical questions

Our advantage: At ProteoGenix, we deliver milligram quantities of recombinant antibodies in as little as 1 week? Our optimized workflows and in-house plasmid preparation accelerate every step of the process. 

2. Expression System and Yields

The choice of expression system, typically CHO or HEK293, can greatly influence antibody quality and yield. However, it is not a one-size-fits-all scenario. Each cell line has its own set of advantages and limitations to consider depending on your construct, timeline, and downstream application. A good provider will advise you on the best system for your molecule and scale.

Key factors to consider: 

• Availability of both HEK and CHO systems
• Expected yields per mL of culture
• Experience with difficult-to-express antibodies

Our advantage: We offer both CHO and HEK platforms, along with expert guidance to determine the right system for your needs. Our optimized protocols consistently deliver high yields and reproducible results, even for complex formats like scFv, Fab, VHH, and bispecifics. 

Learn more about our cell line XtenCHO Race

3. Scalability and Flexibility

Your production needs may evolve as your antibody program moves forward, from microgram quantities for screening to gram-level batches for candidate optimization or preclinical studies. And if your molecule has a therapeutic potential, you might even need to transition to a stable cell line. 

In this context, having a partner who can adapt quickly to your changing goals is essential.  

Key factors to consider: 

• Scalable processes from small- to mid-scale production
• Flexible batch sizes (from a few mL to liters)
• Ability to support the transition to stable cell line generation, if needed

Our advantage: ProteoGenix supports flexible batch sizes from 1 mL to 50 L and beyond. We regularly deliver milligram to gram-scale antibody quantities, and we can support you in transitioning to stable CHO cell lines when you’re ready to scale up.

Explore our production services

4. Quality Control and Analytics

Quality control (QC) ensures each recombinant antibody production step follows the expected standard operating procedures. QC to determine factors such as purity, sensitivity, and specificity must be performed to ensure batch-to-batch consistency. 

What to look for:

• Comprehensive QC tests: Endotoxin testing, purity analysis, aggregation, SDS-PAGE, ELISA, etc.
• Optional add-ons like binding assays or functional testing
• Clear and standardized QC reports

Our advantage: Every batch at ProteoGenix is subject to rigorous QC, including endotoxin testing, SEC-HPLC, SDS-PAGE, and UV-based concentration analysis. We offer custom assays on demand to fit your application. 

See our characterization services

5. Expert Support and Communication

Effective communication is a essential for making informed desicions. A provider who understands your goals, offers the right advice and responds quickly can save you time and stress. 

What to look for:

• Access to scientific experts
• Personalized guidance and troubleshooting
• Fast and proactive communication

Our advantage: At ProteoGenix, your project is supported by a dedicated project manager, your main point of contact and your scientific advisor.  We also plan go/no-go checkpoints at key stages, so you stay in control of your project. 

Speak with our Experts

Questions to Ask Your CRO, and Yourself, before Starting

Choosing the right partner starts with asking the right questions. Here are some key points to clarify before committing to a transient antibody production project:

Questions to ask your provider:

• What is your average turnaround time for [X] scale?
• What expression systems do you recommend for antibodies like mine?
• Can you provide examples of similar projects you’ve handled?
• What QC analyses are included in your standard package?

Questions to ask yourself:

• How much material do I need? and how fast?
• What level of purity or quality do I require at this stage?
• Am I planning to move to stable expression soon?
• Do I need help troubleshooting difficult constructs?
• Is it important for me to have direct access to scientists?

Asking these questions early helps align expectations, reduce risk, and ensure your project gets off to the right start.

Choosing the Right Partner

Transient recombinant antibody production isn’t just a service, it’s a strategic step in your drug development journey. The right partner will not only meet your technical needs but also help you accelerate development, reduce risk, and help to reach the preclinical stage faster.

At ProteoGenix, we combine speed, flexibility, quality, and expertise to support every stage of antibody development. Whether you’re screening a panel of candidates or producing material for preclinical studies, we’re here to help you move forward, faster.

Want to learn more? Contact us to get a quote or speak to one of our experts today.

Contact our team to discuss your antibody project